Liraglutide was well tolerated, with no episodes of hypoglycaemia or diabetic ketoacidosis
When a patient starts a new, potent medication like semaglutide, they are under much closer medical supervision
I have not observed significant differences in the skin issues experienced by people who lose weight via GLP-1 agonists versus other weight loss approaches
Conditions under active investigation include prediabetes, heart failure with preserved ejection fraction, obstructive sleep apnoea, knee osteoarthritis, polycystic ovarian syndrome, and inflammatory bowel disease
They work by different mechanisms to help manage blood sugar levels in people with this condition and can lead to weight loss as a secondary fix
It is universal across all reconstituted peptides